Fig. 2From: Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinomaThe in vitro release curves of a SFN and b TPL from free (SFN + TPL), (SFN + TPL)@LCNPs and (SFN + TPL)@CPLCNPs (n = 3; **p < 0.01 when (SFN + TPL)@CPLCNPs compared with free (SFN + TPL) or (SFN + TPL)@LCNPs)Back to article page